Catalent (CTLT) Stock Forecast & Price Target

$58.68

+0.23 (+0.39%)

(As of 07/26/2024 ET)

Catalent - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 11 Analyst Ratings

Based on 11 Wall Street analysts who have issued ratings for Catalent in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 7 have given a hold rating, and 3 have given a buy rating for CTLT.

Consensus Price Target

$55.65
-5.16% Downside

High Forecast	$63.50
Average Forecast	$55.65
Low Forecast	$42.00

According to the 11 analysts' twelve-month price targets for Catalent, the average price target is $55.65. The highest price target for CTLT is $63.50, while the lowest price target for CTLT is $42.00. The average price target represents a forecasted downside of -5.16% from the current price of $58.68.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$55.65	$54.05	$52.46	$56.25
Forecasted Upside	-5.16% Downside	8.17% Upside	8.40% Upside	19.78% Upside

Get Catalent Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter.

Ad Porter & Company

Nvidia insiders dumping shares

All the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.

To see Porter Stansberry's new AI prediction go here now.

CTLT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTLT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Catalent Stock vs. The Competition

Type	Catalent	Medical Companies	S&P 500
Consensus Rating Score	2.18	2.72	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	-5.16% Downside	3,123.46% Upside	9.18% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
7/11/2024	Royal Bank of Canada 4 of 5 stars	Reiterated Rating	Sector Perform ➝ Sector Perform	$63.50 ➝ $63.50	+10.15%
6/28/2024	Barclays 2 of 5 stars	Boost Target	Equal Weight ➝ Equal Weight	$47.00 ➝ $63.00	+11.98%
4/4/2024	Stephens 4 of 5 stars	Reiterated Rating	Equal Weight ➝ Equal Weight	$63.50	+12.09%
2/6/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$58.00 ➝ $63.50	+6.15%
11/16/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$50.00 ➝ $42.00	+6.17%
11/16/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$45.00 ➝ $53.00	+33.97%
Get the Latest News and Ratings for CTLT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.
11/14/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
9/5/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$62.00	+23.51%
8/31/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underperform ➝ Underperform	$39.00 ➝ $46.00	-8.20%
8/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$52.00 ➝ $55.00	+9.26%
8/15/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$37.00 ➝ $45.00	-0.97%
6/14/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$45.00 ➝ $44.00	+0.34%
5/21/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$90.00 ➝ $45.00	+21.07%
11/2/2022	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	$125.00 ➝ $85.00	+71.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:51 AM ET.

CTLT Forecast - Frequently Asked Questions

What is Catalent's forecast for 2024?: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Catalent is $55.65, with a high forecast of $63.50 and a low forecast of $42.00.
Should I buy or sell Catalent stock right now?: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last year. There is currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CTLT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CTLT, but not buy additional shares or sell existing shares.
Does Catalent's stock price have much upside?: According to analysts, Catalent's stock has a predicted upside of 10.07% based on their 12-month stock forecasts.
What analysts cover Catalent?: Catalent has been rated by research analysts at Barclays, and Royal Bank of Canada in the past 90 days.
Do Wall Street analysts like Catalent more than its competitors?: Analysts like Catalent less than other "medical" companies. The consensus rating for Catalent is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CTLT compares to other companies.